Courtney Davis

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 4.8K citations

Medicine, Internal Medicine, Pharmacotherapy +16

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

Courtney Davis, Huseyin Naci, Evrim Gurpinar et al. · BMJ · 2017 · 605 citations · Full text

Medicine, Oncology, Pharmacology +15

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis

Huseyin Naci, Courtney Davis, Jelena Savović et al. · BMJ · 2019 · 244 citations · Full text

Medicine, Oncology, Pharmacology +17

Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene.

N.R. Kitteringham, Courtney Davis, Nigel Howard et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 95 citations

Medicine, Genetics, Pharmacology +17

Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States

Maximilian Salcher‐Konrad, Huseyin Naci, Courtney Davis · Milbank Quarterly · 2020 · 92 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17